Even though it has been shown previously that RyR1 is leaky in dystrophic muscle and contributes to the disease phenotype, and drugs that stabilize RyR1 are known to be effective in muscular dystrophy 23, we could not see a similar effect with Dantrolene in this experiment. The gene discussed is RYR1; the disease is muscular dystrophy.